share_log

City of Hope's Dr. Alexis LeVee Awarded Biocodex Microbiota Foundation's 2024 USA National Research Grant

City of Hope's Dr. Alexis LeVee Awarded Biocodex Microbiota Foundation's 2024 USA National Research Grant

希望之城的亚历克斯·勒维博士获得了Biocodex微生物组基金2024年美国国家研究拨款
PR Newswire ·  12/10 21:45

BEDMINSTER, N.J., Dec. 10, 2024 /PRNewswire/ -- The Biocodex Microbiota Foundation, an independent organization founded by Biocodex, has awarded its 2024 USA Microbiome Research Grant to Alexis LeVee, MD, Chief Hematology and Medical Oncology Fellow at City of Hope, a national cancer research and treatment organization ranked among the nation's top 5 cancer centers by U.S. News & World Report.

美国新泽西州贝德敏斯特,2024年12月10日 /PRNewswire/ -- Biocodex微生物组基金会是一家独立组织,由Biocodex创办,已将2024年美国微生物组研究资助授予市希望的血液学和医疗肿瘤学首席研究员Alexis LeVee博士,该组织是一家国家癌症研究和治疗机构,按照美国新闻与世界报道排名位列全国前五名癌症中心。

Dr. LeVee's pioneering research focuses on the potential for gut microbiome compositions to predict and enhance responses to immunotherapy for patients with early-stage triple-negative breast cancer (TNBC), a challenging and aggressive form of breast cancer.

LeVee博士的先锋研究集中于肠道微生物组组成预测和增强早期三阴性乳腺癌(TNBC)患者对免疫治疗反应的潜力,这是一种具有挑战性和侵袭性的乳腺癌形式。

The $50,000 grant is awarded to early-career U.S.-based researchers investigating the influence of gut microbiota on human health. This marks the eighth year the Foundation has awarded the grant, totaling $400,000 in support of innovative microbiome research across fields such as oncology, neurology, and metabolic disorders.

该项50,000美元的资助授予美国本土早期职业研究人员,研究肠道微生物群对盈健医疗的影响。这是该基金会第八年颁发该资助,总计400,000美元,用于支持抗癌医药、神经学和代谢疾病等领域的创新微生物组研究。

City of Hope is accelerating its research and focus on the direct correlation between a healthy gut and the effectiveness of immune therapies, such as CAR T cell therapy. Dr. LeVee's project builds on data from the PEARL trial, which investigated patient outcomes when radiation therapy is combined with immunotherapy in treating early-stage TNBC. Her research will analyze stool samples and immune markers in tumor biopsies to determine if certain gut bacteria can predict positive responses to this therapy. This study may uncover a new microbiome-based biomarker to personalize and improve treatment for breast cancer patients.

市希望正在加速其研究,专注于健康肠道与免疫疗法效果之间的直接关联,例如CAR T细胞治疗。LeVee博士的项目基于PEARL试验的数据,该试验研究了在治疗早期TNBC时放疗与免疫治疗结合的患者结果。她的研究将分析粪便样本和肿瘤活检中的免疫标志物,以判断某些肠道细菌是否可以预测对该疗法的积极反应。这项研究可能会揭示一种新的基于微生物组的生物标志物,以个性化和改善乳腺癌患者的治疗。

"This Biocodex Microbiota Foundation grant will significantly advance our ability to explore the microbiome's complex interactions with the immune system," Dr. LeVee said. "With this support, we at City of Hope can delve deeper into how specific gut bacteria may optimize immunotherapy responses for breast cancer patients, potentially leading to more precise and effective treatment approaches."

“这项Biocodex微生物组基金会的资助将显著推动我们探索微生物组与免疫系统复杂互动的能力,”LeVee博士说。“有了这份支持,我们在市希望可以更深入地研究特定的肠道细菌如何优化乳腺癌患者对免疫治疗的反应,可能会导致更精确和有效的治疗方法。”

Marie-Emmanuelle LeGuern, Chairman of the Biocodex Microbiota Foundation, remarked on the importance of this year's grant: "We are honored to support Dr. LeVee's groundbreaking work, which exemplifies the transformative potential of microbiome research. By advancing our understanding of the microbiome's role in cancer treatment, we are one step closer to realizing innovative, microbiota-based solutions that improve patient care and outcomes."

Biocodex微生物组基金会董事长Marie-Emmanuelle LeGuern提到了今年资助的重要性:“我们很荣幸支持LeVee博士的开创性工作,这 exemplifies 微生物组研究的变革潜力。通过加深我们对微生物组在抗癌治疗中作用的理解,我们离实现创新的、基于微生物组的解决方案,以改善患者护理和治疗效果又近了一步。”

The Biocodex Microbiota Foundation's annual grant is part of its global commitment to advancing scientific knowledge of microbiota's role in health and disease. This year's research applications were reviewed by an esteemed judging panel from the US Biocodex Microbiota Foundation's scientific board, comprised of Dr. Ruth Ann Luna from Texas Children's Hospital and Baylor College of Medicine, Dr. Mindy Engevik from the Medical University of South Carolina and Dr. Erica Sonnenburg from Stanford University.

Biocodex微生物组基金会的年度资助是其全球承诺的一部分,旨在推进对微生物组在健康和疾病中作用的科学知识。今年的研究申请由来自美国Biocodex微生物组基金会科学委员会的杰出评审小组审阅,该小组由德克萨斯儿童医院和贝勒医学院的Ruth Ann Luna博士、南卡罗来纳医学大学的Mindy Engevik博士和斯坦福大学的Erica Sonnenburg博士组成。

2025 USA Call for Projects

2025美国项目征集

The Biocodex Microbiota Foundation will move its open call for applications for its annual USA research grant from June to January 2025. The US grant theme for 2025 will be Beyond the Gut: The Role of the Gut Microbiome on Whole Body Health. The $50,000 grant, now in its 9th year, is juried by a panel of medical and scientific experts. It will be awarded to a US-based investigator studying gut microbiota in human health and disease. The application portal will be open in mid-January 2025. More information on the grant can be found at - USAFoundation@Biocodex.com

Biocodex微生物组基金会将其年度美国研究资助的开放申请时间从6月调整至2025年1月。2025年的美国资助主题是“超越肠道:肠道微生物组对全身健康的作用”。该资助金额为50,000美元,目前已进入第9年,由医学和科学领域的专家小组进行评审。该资助将颁发给一名研究人类健康和疾病中肠道微生物组的美国研究者。申请门户将在2025年1月中旬开放。有关资助的更多信息可通过 - USAFoundation@Biocodex.com 查找。

About the Biocodex Microbiota Foundation
The Biocodex Microbiota Foundation's mission is to support research into microbiota and its interaction with various pathologies. Research is supported through grants given to projects that investigate the implication of microbiota in human health. The Biocodex Microbiota Foundation supports both foundational and applied research and projects are selected annually by a committee of independent scientists.

关于Biocodex微生物组基金会
Biocodex微生物组基金会的使命是支持对微生物组及其与各种病理的相互作用的研究。通过给予研究资金来支持研究项目,这些项目调查了微生物组在人类健康中的影响。Biocodex微生物组基金会同时支持基础研究和应用研究,年度由独立科学家委员会选定项目。

The Foundation's primary activity remains awarding annual grants to innovative scientific research projects that explore the structure and impact of microbiota. The Foundation also runs and helps establish programs to improve our understanding of microbiota and disseminates this knowledge as widely as possible, including in scientific communities and via public projects aimed at improving human health.

基金会的主要活动仍然是向探索微生物组结构及影响的创新科学研究项目颁发年度资助。基金会还开展并协助建立程序,以加深我们对微生物组的理解,并尽可能广泛地传播这一知识,包括在科学界和通过旨在改善人类健康的公共项目。

The Biocodex Microbiota Foundation is a non-profit, general-interest organization. For more information, visit Biocodex Microbiota Foundation.

Biocodex微生物组基金会是一个非营利性、公共利益组织。欲了解更多信息,请访问Biocodex微生物组基金会。

SOURCE Biocodex Microbiota Foundation

来源 Biocodex微生物组基金会

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想让贵公司的资讯在PRNEWSWIRE.COM上特色展示吗?

440k+
440k+

Newsrooms &
新闻编辑室和

Influencers
意见领袖
9k+
9k+

Digital Media
数字媒体

Outlets
Outlets
270k+
270k+

Journalists
记者

Opted In
已选择加入
GET STARTED
开始
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发